Robinswood Financial’s Gilead Sciences GILD Stock Holding History

Robinswood Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.95K	Buy	55 +1	+2%	+$132	﹤0.01%	319
2026 Q1	$7.62K	Hold	54	–	–	﹤0.01%	299
2025 Q4	$6.67K	Hold	54	–	–	﹤0.01%	287
2025 Q3	$5.99K	Hold	54	–	–	﹤0.01%	289
2025 Q2	$5.99K	Hold	54	–	–	﹤0.01%	288
2025 Q1	$6.05K	Hold	54	–	–	﹤0.01%	280
2024 Q4	$4.99K	Hold	54	–	–	﹤0.01%	247
2024 Q3	$4.53K	Sell	54 -116	-68%	-$8.85K	﹤0.01%	267
2024 Q2	$11.7K	Buy	170 +116	+215%	+$7.74K	﹤0.01%	199
2024 Q1	$3.94K	Hold	54	–	–	﹤0.01%	197
2023 Q4	$4.37K	Hold	54	–	–	﹤0.01%	192
2023 Q3	$4.05K	Hold	54	–	–	﹤0.01%	197
2023 Q2	$4.16K	Buy	+54	New	+$4.31K	﹤0.01%	176

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Robinswood Financial's GILD Position: Q2 2026 in Review

Robinswood Financial increased its Gilead Sciences (GILD) stake by 1.9% in Q2 2026, buying an estimated $132 and bringing the position to 55 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #319.

Robinswood Financial first reported a position in GILD in Q2 2023 and has held it in 13 quarters since. The position peaked at $11.7K in Q2 2024. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Robinswood Financial held 55 shares of Gilead Sciences worth $6.95K as of Q2 2026.
Robinswood Financial bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
Gilead Sciences made up ﹤0.01% of Robinswood Financial's portfolio in Q2 2026, its #319 holding.
Robinswood Financial first reported a position in Gilead Sciences in Q2 2023 and has held it in 13 quarters since.
Robinswood Financial's Gilead Sciences position peaked at $11.7K in Q2 2024.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.